3573. Adulteration and misbranding of conjugated estrogens.   U. S. v. 3 Bot
tles    *    *    *.    (F. D. C. No. 31220.   Sample No. 813-L.)
LIBEL FILED :   June 27,1951, Southern District of Florida.
ALLEGED SHIPMENT :   During or about December 1950, by the Eobin Pharmacal
Corp., from New York, N. Y.
PRODUCT :   3   1,000-tablet bottles of conjugated estrogens at Miami Beach, Fla.
Analysis showed that the product contained a total amount of estrogenic
steroids calculated to 0.59 milligram of sodium estrone sulfate per tablet.
NATURE OF CHARGE:   Adulteration, Section 501 (c), the strength of the article
differed from that which it was represented to possess, namely, 1.25 mg. of
estrogens in their naturally occurring water-soluble form, expressed as sodium
estrone sulfate.
Misbranding, Section 502 (a), the label statement "Each tablet contains
1.25 mg. of estrogens in their naturally occurring water soluble form, ex-
pressed as sodium estrone sulfate" was false and misleading as applied to
an article which contained less than the stated amount of estrogens.
DISPOSITION :   August 17, 1951.   Default decree of forfeiture and destruction.
DRUGS AND DEVICES ACTIONABLE BECAUSE OF FALSE AND
MISLEADING CLAIMS*